Dr Karpouzas discusses his research that evaluated whether β-2 glycoprotein 1 IgA antibodies can predict coronary plaque burden and progression, and whether the antibodies moderate the effect of...
In this podcast, Frank LoVecchio, MD, discusses typical and atypical presentations of community-acquired bacterial pneumonia (CABP), as well as important considerations for health care providers when...
Molly Jeffery, PhD, from the Mayo Clinic, discusses her study on the rates of opioid use in the United States, which have remained largely unchanged over the past decade despite increased awareness...
In this podcast, William Schaffner, MD, answers our questions about herpes zoster, pneumococcal disease, and COVID-19 vaccinations for adults aged 50 years or older.
